Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page
- Check2 days agoChange DetectedResults have been posted with detailed efficacy and patient-reported outcome measures (e.g., ACR 20 at Week 16, PASI, HAQ-DI, DAS28-CRP, SF-36, PsAID, DAPSA, PsARC, BASDAI, SvdH, etc.). The Cali, Colombia site entry was updated to indicate Cali (760042), replacing the previous Santiago de Cali listing.SummaryDifference4%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page updates to v3.2.0 and adds a government funding operating-status notice, replacing the previous v3.1.0 reference.SummaryDifference2%

- Check31 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content; core page content appears to be re-scoped rather than expanded.SummaryDifference0.2%

- Check45 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed, indicating a small UI cleanup accompanying the version bump.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page has been updated to reflect the submission of results, and the version has been incremented to v3.0.1, indicating a new release. The previous version noted 'No Results Posted', which has been removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous location entries across various countries and the removal of some previously listed locations. Additionally, there are changes in the MedlinePlus related topics, with some topics being added while others were removed.SummaryDifference16%

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.